Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 131,228 | 248,334 | 65,202 | 82,417 | 90,638 |
| Marketable Securities | 204,043 | 174,076 | 209,881 | 228,412 | 235,674 |
| Receivables | 2,986 | 11,371 | 13,835 | 13,229 | 4,753 |
| Other current assets | 710 | 1,324 | 0 | 0 | 0 |
| TOTAL | $346,283 | $441,423 | $294,174 | $328,450 | $338,301 |
| Non-Current Assets | |||||
| PPE Net | 15,130 | 20,944 | 29,451 | 31,867 | 31,506 |
| Investments And Advances | 81,182 | 27,001 | 6,490 | 10,368 | 22,108 |
| Intangibles | 2,595 | 2,883 | 3,171 | 3,459 | 3,748 |
| Other Non-Current Assets | 113,260 | 39,312 | 19,998 | 21,316 | 21,281 |
| TOTAL | $212,167 | $90,140 | $59,110 | $67,010 | $78,643 |
| Total Assets | $558,450 | $531,563 | $353,284 | $395,460 | $416,944 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,089 | 14,073 | 7,815 | 14,470 | 13,857 |
| Accrued Expenses | 11,932 | 17,295 | 26,789 | 15,632 | 16,543 |
| Other current liabilities | 23,953 | 16,227 | 16,136 | 15,836 | 622 |
| TOTAL | $51,580 | $51,511 | $54,445 | $49,407 | $34,512 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,606 | 3,916 | 3,705 | 3,469 | 3,490 |
| Other Non-Current Liabilities | 83,569 | 17,270 | 16,555 | 29,968 | 13,125 |
| TOTAL | $84,312 | $19,044 | $50,082 | $64,362 | $48,015 |
| Total Liabilities | $135,892 | $70,555 | $104,527 | $113,769 | $82,527 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,612 | 98,509 | 78,560 | 78,315 | 77,589 |
| Common Shares | 10 | 10 | 8 | 8 | 8 |
| Retained earnings | -788,669 | -743,826 | -735,581 | -685,281 | -615,396 |
| Other shareholders' equity | 141 | -201 | -278 | -415 | -689 |
| TOTAL | $422,558 | $461,008 | $248,757 | $281,691 | $334,417 |
| Total Liabilities And Equity | $558,450 | $531,563 | $353,284 | $395,460 | $416,944 |